Brief: BioArctic And Lilly Sign Research, Collaboration Agreement
BRIEF-BioArctic And Lilly Sign Research, Collaboration Agreement June 22 (Reuters) - BioArctic AB BIOAb.ST:
CO AND LILLY SIGN RESEARCH, COLLABORATION AGREEMENT COMBINING LILLY COMPOUND WITH CO'S BRAINTRANSPORTER TECHNOLOGY
TO RECEIVE $30 MILLION UPFRONT PAYMENT FROM LILLY
ELIGIBLE FOR UP TO $770 MILLION IN MILESTONE PAYMENTS
Source text: ID:nWkrbwlfYD
Further company coverage: [BIOAb.ST]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million